14-day Premium Trial Subscription Sign Up For FreeGet Free

Verve Therapeutics, Inc. Stock Forecast NASDAQ:VERV

$35.74 (11.13%)

Volume: 530k

Closed: Dec 07, 2021

Hollow Logo Score: -2.263

Verve Therapeutics, Inc. Stock Forecast

$35.74 (11.13%)

Volume: 530k

Closed: Dec 07, 2021

Score Hollow Logo -2.263
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 80 ] RSI14 is 27 and the stock is currently not being overbought or oversold

Volatile ride for Verve Therapeutics, Inc. stock price on Tuesday moving between $32.88 and $36.29
(Updated on Dec 07, 2021)


Sell candidate since 2021-11-12 Loss -25.96%

The Verve Therapeutics, Inc. stock price gained 11.13% on the last trading day (Tuesday, 7th Dec 2021), rising from $32.16 to $35.74. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 10.37% from a day low at $32.88 to a day high of $36.29. The price has been going up and down for this period, and there has been a -7.24% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 210 thousand more shares were traded than the day before. In total, 530 thousand shares were bought and sold for approximately $18.96 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -33.38% during the next 3 months and, with a 90% probability hold a price between $20.75 and $33.19 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 11.90%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Verve Therapeutics, Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $43.21. On a fall, the stock will find some support from the short-term average at $33.35. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

Verve Therapeutics, Inc. finds support from accumulated volume at $35.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $3.41 between high and low, or 10.37%. For the last week, the stock has had a daily average volatility of 10.20%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Verve Therapeutics, Inc. stock A Buy?

Verve Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.263

Predicted Opening Price for Verve Therapeutics, Inc. of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$34.97 $35.74 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Sep 23, 2021 "Stifel Nicolaus" gave "" rating for VERV. The price target was set to $51.94+10.5%.

Volatility and Risk
Daily Average Volatility: 10.20 %
Overall Risk: Very High High Medium Low Very Low
Volatility
10.20 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $38.53
Price: $35.74
Support: $35.06

VERV Insider Trading Show all Trades

INSIDER POWER

0.278

Last 59 transactions
Buy: 37 247 261 | Sell: 134 210 192 (Shares)
Date Action Amount Person Type
Dec 02, 2021 Buy 4 700 Adelman Burt A Common Stock
Dec 02, 2021 Buy 4 000 Ashe Andrew D. Common Stock
Nov 29, 2021 Buy 7 500 Dorval Allison Restricted Stock Units
Nov 29, 2021 Buy 135 000 Dorval Allison Stock Option (right to buy)
Jun 21, 2021 Sell 4 104 416 Yeshwant Krishna Series B Preferred Stock
Show all Insider Trades
INSIDER POWER

0.278

Last 59 transactions
Buy: 37 247 261 | Sell: 134 210 192 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 38.38 7.39 %
37.08 3.74 %
36.27 1.49 %
Current price: 35.74
Support 33.67 -5.80 %
32.86 -8.05 %
31.56 -11.70 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 43.94 22.94 %
43.05 20.45 %
38.53 7.81 %
Current price 35.74
Support 35.06 -1.90%
34.08 -4.64%
31.94 -10.63%

Click to get the best stock tips daily for free!

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT